Cannabinoids and addictive behavior;Cannabinoides y conducta adictiva

Adicciones

Volumn 12, Issue SUPPL. 2, 2000, Pages 97-108

  Navarro, M ^a   Rodriguez de Fonseca, F ^a  

^a Facultad de Psicologia   (Spain)

Author keywords

Addiction; Animal models; Brain; Cannabinoid system; Cannabis; Dependence; Dopamine; Opiods; Reward system

Indexed keywords

CANNABINOID; CANNABIS; ENKEPHALIN; MEMBRANE RECEPTOR; OPIATE AGONIST; OPIATE RECEPTOR; PSYCHOTROPIC AGENT;

ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; CANNABIS ADDICTION; CONDITIONING; DOPAMINERGIC SYSTEM; DRUG ABUSE; DRUG SELF ADMINISTRATION; NONHUMAN; PLACE PREFERENCE; REVIEW; REWARD; WITHDRAWAL SYNDROME;

EID: 0033637406     PISSN: 02144840     EISSN: None     Source Type: Journal    
DOI: 10.20882/adicciones.674     Document Type: Review

References (55)

1. Neurobiology of marijuana abuse
2. Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A
3. The neurobiology of cannabinoid dependence: Sex differences and potential interactions between cannabinoid and opioid systems
4. Marijuana: A continuing continuing concern for pediatricians
5. Cannabis and schizophrenia: A longitudinaal study of Swedish conscripts
6. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalant: Basic findings from the national comorbidity survey
7. Dependence on thtrahydrocannabinol in rhesus monkeys
8. Cannabis and the brain
9. 9-tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex
10. Intracraneal self-stimulation in relation to the ascending dopaminergic systems of the midbrain: A moveable electrode mapping study
11. Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders
12. Cannabinoid Pharmacology
13. Mesolimbic dopaminergic decline after cannabinoid withdrawal
14. Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal
15. Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: Electrophysiological and biochemical evidence
16. Towards a cannabinoid hypothesis of schizophrenia: Cognitive impairments due to dysregulation of the endogenous cannabinoid system
17. Nigral transplants reinnervating the dopamine-depleted neostriatum can sustain intracranial self-stimulation
18. An abstinence syndrome following chronic administration of delta-9-tetrahydrocannabinol in rhesus monkeys
19. 9-tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors
20. Isolation, structure elucidation and partial synthesis of an active constituent of hashish
21. Brain reward mechanisms
22. Marijuana's interaction with brain reward systems: Update 1991
23. Cannabinoid transmission and reward-related events
24. The CB1 cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the rat
25. Clinical studies of cannabis tolerance and dependence
26. The health and psychological consequences of cannabis use
27. Abstinence symptons following oral THC administration to humans
28. Morphine-dependent rats: Blockade of precipitated abstinence by tetrahydrocannabinol
29. Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with Δ-9-tetrahydrocannabinol
30. Neuroscience of addiction
31. Changes in aggressive behavior during withdrawal from long-term marijuana use
32. Levonantradol for chemotherapy-induced emesis: Phases I-II oral administration
33. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice
34. Cannabinoid receptor localization in brain
35. Pharmacological and biochemical interactions between opioids and cannabinoids
36. Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug naive mice
37. Characterization of the acute endocrine actions of HU-210, a potent synthetic cannabinoid in rats
38. 9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity
39. a induces anxiety-like responses in the rat
40. The analgesic properties of delta-9-tetrahydrocannabinol and codeine
41. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain
42. Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission
43. Pathophysiological basis of vulnerability to drug abuse: Role of an interaction between stress, glucorticoids and dopaminergic neurons
44. 9-tetrahydrocannabinol on catecholamines uptake and release in hypothalamic and striatal synaptosomes
45. The residual neuropsychological effects of cannabis: The current status of research
46. Effects of intravenous tegrahydrocannabinol on experimental and surgical pain. Psychological correlate of the analgesic response
47. 37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats
48. 9-tetrahydrocannabinol in rats: Possible role of pituitary-adrenal axis
49. Nucleus accumbens dopamine and rate of responding: Neurochemical and behavioral studies
50. Chemistry and pharmacology of cannabis
51. A neural substrate for prediction and reward
52. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common M1 opioid receptor mechanism
53. Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine